Lam Research (LRCX): CEO exercised options on 113K shares
Timothy Archer, CEO at Lam Research, reported an option exercise of 113K shares.
- 113K
- Shares · @ $17.68
- Traded
- Dec 17, 2025
- Filed
- Dec 18, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
- Oct 27, 2025Insider · 1 personInsiders: 2 sales (~$1.4M)
- Nov 3, 2025InsiderDirector sold ~$208K of LRCX shares in the open market
- Nov 4, 2025Company filing · Form 8-K · Shareholder rights, Executive changeChanged a top executive or board member, and changed the rights of its shareholders (and 2 more items)
- Nov 7, 2025InsiderDirector sold ~$4.8K of LRCX shares in the open market
- Nov 14, 2025InsiderCFO sold ~$6.04M of LRCX shares in the open market
- Nov 20, 2025Government · Federal Register noticePhasedown of Hydrofluorocarbons: Notice of 2026 Allowance Allocations for Production and Consumption of Regulated Substances Under the American Innovation and Manufacturing Act of 2020, and Notice of Final Actions Establishing Administrative Consequences
- Dec 17, 2025Insider · 1 personInsiders: 2 sales (~$26.8M)
What came next
- Dec 29, 2025CongressDisclosed purchase of LRCX — reported range $50,001 - $100,000
- Jan 8, 2026Congress · 2 peopleMembers of Congress: 3 sales
- Jan 16, 2026CongressDisclosed sale of LRCX — reported range $1,001 - $15,000
- Jan 28, 2026Company filing · Form 8-K · ResultsReported its results
- Jan 30, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 3, 2026, the Board of Directors (the “Board”) of Lam Research Corporation (the “Company”), pursuant to applicable provisions of the Company’s Amended and Restated Bylaws, appointed Anirudh Devgan, Ph.D., age 56, as a director of the Company, effective immediately.”
- Jan 30, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 3, 2026, Lam Research Corporation (the “Company”) filed a Current Report on Form 8-K (the “Initial Form 8-K”) wherein it reported that it had issued a press release (the “Exhibit 99.2 Press Release”) announcing the retirement of Patrick J. Lord, Ph.D. and the appointment of Seshasayee (Sesha) Varadarajan as the Company’s executive vice president and chief operating officer.”
- Feb 3, 2026CongressDisclosed purchase of LRCX — reported range $15,001 - $50,000
- Feb 6, 2026Insider · 1 personInsiders: 2 sales (~$7.9M)
- Feb 26, 2026Congress · 1 personMembers of Congress: 2 sales
- Mar 2, 2026Insider · 2 peopleInsiders: 2 sales (~$10.2M)
- Mar 4, 2026Insider · 2 peopleInsiders: 2 sales (~$11.5M)
- Mar 12, 2026CongressDisclosed purchase of LRCX — reported range $1,001 - $15,000
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Lam Research
For Lam Research, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 6 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LRCX page.
Other recent filings by Timothy Archer, President and CEO
- SEC Form 4 at Lam Research (LRCX)Oct 26, 2026
- SEC Form 4 at Lam Research (LRCX)Sep 10, 2026
- SEC Form 4 at Lam Research (LRCX)Aug 7, 2026
- SEC Form 4 at Lam Research (LRCX)Jul 6, 2026
- SEC Form 4 at Lam Research (LRCX)Dec 18, 2025
The full history of Timothy Archer, President and CEO is on the profile page.
How this filing works
Explore the data
Common questions
Which Lam Research (LRCX) insider traded, and how much?
Timothy Archer, CEO at Lam Research, reported an option exercise of 113K shares. At $17.68.
When did it happen, and when was it made public?
Traded: Dec 17, 2025. Filed: Dec 18, 2025. That is 1 day between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Lam Research recently?
For Lam Research, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 6 fund holdings reports (13F) dated in the last 90 days. They are listed on the LRCX page.
Does this mean LRCX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Lam Research
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- House Clerk periodic transaction reportNov 12, 2026
Everything OQRO holds on this company is on its LRCX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
